Migrén: vizsgálatok itt: Kanada
20 trials · From ClinicalTrials.gov, checked 2026. november 10.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleStudy of EVO756 in Adults With Migraine
- Where
- Québec
- Életkor
- 18 év to 64 év
- People
- 330 worldwide
- Run by
- Evommune, Inc.
See details and how to joinNCT07616128 - 3. fázisTaking peopleEary Infusion of Eptinezumab for TreatmEnt of ACute Post-Traumatic Headaches (ELITE-ACT)
- Where
- Toronto
- Életkor
- 18 év to 65 év
- People
- 80
- Run by
- Sunnybrook Health Sciences Centre
See details and how to joinNCT07191145 - 3. fázisTaking peopleRandomized Study in Children and Adolescents With Migraine: Acute Treatment
- Where
- Kelowna BC, Sherbrooke
- Életkor
- 6 év to 17 év
- People
- 2100 worldwide
- Run by
- Pfizer
See details and how to joinNCT04649242 · EU 2024-512743-23-00 - 3. fázisTaking peopleA Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine
- Where
- Ajax, Edmonton, London, Penticton, Victoria
- Életkor
- 12 év to 17 év
- People
- 285 worldwide
- Run by
- H. Lundbeck A/S
See details and how to joinNCT04965675 · EU 2024-510656-13-00 - 3. fázisTaking peopleEfficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
- Where
- Vancouver
- Életkor
- 6 év to 17 év
- People
- 640 worldwide
- Run by
- Pfizer
See details and how to joinNCT05156398 · EU 2024-512382-13-00 - 3. fázisTaking peopleA Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
- Where
- Ajax, London, Victoria
- Életkor
- 6 év to 17 év
- People
- 600 worldwide
- Run by
- H. Lundbeck A/S
See details and how to joinNCT05164172 · EU 2022-502917-27-00 - 3. fázisTaking peopleA Study of Eptinezumab in Pediatric Participants With Episodic Migraine
- Where
- Ajax, London, Penticton, Victoria
- Életkor
- 6 év to 17 év
- People
- 315 worldwide
- Run by
- H. Lundbeck A/S
See details and how to joinNCT05897320 · EU 2022-502538-14-00 - 3. fázisTaking peopleA Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
- Where
- London, Montreal
- Életkor
- 12 év to 17 év
- People
- 420 worldwide
- Run by
- AbbVie
See details and how to joinNCT06810505 · EU 2024-513836-28-00 - 3. fázisTaking peopleA Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
- Where
- Edmonton, London, Montreal
- Életkor
- 6 év to 17 év
- People
- 450 worldwide
- Run by
- AbbVie
See details and how to joinNCT05711394 · EU 2022-501100-94-00 - 3. fázisCsak meghívásosEptinezumab as an Adjunct to Standard of Care for Migraine in an Acute Emergency Context
- Where
- New Westminster, Surrey
- Életkor
- 19 év to 75 év
- People
- 102
- Run by
- Dr George Medvedev
See details and how to joinNCT06428838 - No phaseNot yet taking people in KanadaNeuromodulation During the Prodrome to Prevent Disabling Migraine Attacks in Youth
- Where
- Calgary
- Életkor
- 8 év to 18 év
- People
- 30
- Run by
- University of Calgary
See details and how to joinNCT07772427 - 3. fázisTaking peopleA Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine
- Where
- Brampton, Halifax, Kelowna, Lévis, Red Deer, Sarnia, Surrey
- Életkor
- 18 év to 45 év
- People
- 723 worldwide
- Run by
- Pfizer
See details and how to joinNCT06641466 · EU 2024-517121-10-00 - No phaseNot yet taking people in KanadaSelf-Hypnosis Training for Migraine Management (HYlaMI): A Pilot and Proof-of-Concept Study
- Where
- Montreal
- Életkor
- 18 év and over
- People
- 40
- Run by
- Ciusss de L'Est de l'Île de Montréal
See details and how to joinNCT07644299 - 3. fázisTaking peopleMulti-center RCT of IV Ketamine Efficacy and Safety in Chronic Daily Headaches
- Where
- Toronto
- Életkor
- 18 év to 75 év
- People
- 56
- Run by
- University Health Network, Toronto
See details and how to joinNCT05306899 - 2. fázisTaking peopleCannabis for the Prophylactic Treatment of Migraine
- Where
- Calgary
- Életkor
- 25 év and over
- People
- 72
- Run by
- University of Calgary
See details and how to joinNCT03972124 - No phaseNot yet taking people in KanadaExploring Mild Electrical Vestibular Stimulation as a New Treatment for Dizziness and Migraine Symptoms
- Where
- Calgary
- Életkor
- 18 év and over
- People
- 50
- Run by
- University of Calgary
See details and how to joinNCT07368140 - No phaseTaking peopleObservational Study to Assess Adverse Events When Adult Female Participants Are Treated With Ubrelvy (Ubrogepant) or Qulipta (Atogepant) During Pregnancy
- Where
- Ottawa
- Életkor
- 18 év and over
- People
- 1884 worldwide
- Run by
- AbbVie
See details and how to joinNCT05158894 - No phaseNot yet taking people in KanadaEvaluation of a Mind-Body Based Approach for Chronic Pain Treatment
- Where
- Chilliwack
- Életkor
- 19 év to 75 év
- People
- 100
- Run by
- University of the Fraser Valley
See details and how to joinNCT07143396 - 3. fázisCsak meghívásosLong-term Extension Study to Assess Adverse Events of Oral Atogepant Tablets in Pediatric Participants (6 to 17 Years of Age) With Migraine
- Where
- Edmonton, Montreal
- Életkor
- 6 év to 17 év
- People
- 650 worldwide
- Run by
- AbbVie
See details and how to joinNCT05707949 · EU 2022-501099-24-00 - 2. fázisTaking peopleCannabis for Chronic Headaches in Adolescents: the CAN-CHA Trial
- Where
- Halifax, Toronto, Vancouver
- Életkor
- 14 év to 17 év
- People
- 20
- Run by
- University of Manitoba
See details and how to joinNCT05337033